openPR Logo
Press release

Bioreactors Market - Global Industry Insights, Trends, 2026

08-09-2018 04:05 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Bioreactors Market - Global Industry Insights, Trends, 2026

Bioreactor is an engineered or manufactured vessel that is used in the production of wide range of biological products. Industrial bioreactor is a vessel in which biochemical process is carried out using microbes and animal cells or biologically active compounds that are derived from living cells. Bioreactors are cylindrical in shape with capacity of liters to cubic meters and is the most important component involved in bioprocessing. Fermentation processes such as wine, and beer production are carried out in bioreactors. Bioreactors for large scale production of therapeutic products are made of stainless steel. In biopharmaceutical companies, small glass bioreactors are used for research and development purpose and for scale up activities. Another type of bioreactors are disposable bioreactors, which are meant for single use and hence are called as single-use bioreactors. It is generally used for extensive research and manufacturing. Bioreactors can operate in batch, fed batch, and continuous stirred tank processes. Bioreactors are used to produce therapeutics, which include monoclonal antibodies, vaccines, stem cells, and gene modified cells.

Download PDF Brochure @ www.coherentmarketinsights.com/insight/request-pdf/1593

Market Drivers

The efficiency of single-use bioreactors has increased across pharmaceutical industries in terms of production, quality control, and procurement. Single-use bioreactors offer advantages such as consistency in production, increase in speed of manufacturing, reduced operational cost, and reduction in manufacturing time of finished dosage form, which foster growth of bioreactors market. In 2016, as per the National Centre for Biotechnology Information (NCBI), operational cost per gram of monoclonal antibody production (mAb) for single-use bioreactor is around 22% lower than conventional system, mainly due to less labor, utilities, maintenance, and waste. For commercial scale of monoclonal antibody production (mAb), conventional fed-batch bioreactors usually require 10000L – 25000L stainless steel tank to culture cells and produce yield of 2-6 g/L. However, single-use bioreactors employ continuous cell culture supply in 500L - 2000L tank and produces 10 - 30 times higher cell density.

Therefore, more quantity of products can be produced by using this single-use bioreactors, with less space and capital cost. Other factors that contribute to growth of the market include low water usage by single-use systems, less floor space requirement, and low risk of cross contamination in single-use system. Furthermore, in 2016, a case study by Cambridge Healthtech Institute stated that by using single-use (SU) bioreactors, there can be an annual savings of US$ 250,000 in water generation for injections and US$ 60,000 in labor time required to set up and cleaning of stainless steel tank. These factors are expected to drive growth of the bioreactors market over the forecast period.

Moreover, in bioprocessing, enzymes used are specific in their action and produce a pure product. Diseases such as diabetes and anemia are widespread globally, and according to the World Health Organization (WHO), in 2014, around 415 million people were living with diabetes, which indicates the need for increasing availability of bioprocessed products at faster rates, wherein, advanced bioreactors could be useful. For instance, bioprocessed products such as Amaryl manufactured by Sanofi Aventis U.S. Llc, and Acarbose by Emcure Pharmaceutical Ltd. are used as anti-diabetic drugs. Thus, implementation of single-use bioreactors has made clinical and commercial production of biopharmaceuticals fast and efficient in limited time and has reduced the cost associated with production, in turn driving growth of bioreactors market.

Market Regional Insights

North America is expected to hold dominant position in bioreactors market due to presence of major biopharmaceutical manufacturing companies. Biopharmaceutical companies such as Gilead Science, Inc., Amgen, and Biogen, Inc. in the U.S. actively conducts research on novel therapies for the treatment of various diseases. Research of therapies associated with oncology such as monoclonal antibodies require usage of bioreactors on small as well as large scale for production purposes. Furthermore, according to the National Centre for Biotechnology Information (NCBI), in 2014, 65.6% of the clinical scale manufacturers and around 42% of the commercial manufacturers used single-use bioreactors to improve their bioprocessing. Europe is expected to witness significant growth rate in the bioreactors market due to increasing usage of bioreactors in biopharmaceutical companies. According to the Organization for Economic Co-operation and Development (OECD), in 2015, around 1,700 biopharmaceutical companies, which utilize bioreactors, are from Europe.

Access Table of Content (TOC) Of the Report @ www.coherentmarketinsights.com/ongoing-insight/toc/1593

Key players operating in bioreactors market include Thermo Fisher Scientific, Inc., Merck KGaA, GE Healthcare, Pall Corporation, ZETA Holdings GmbH, Sartorius AG BBI, Solaris, Praj HiPurity Systems Limited, BiOENGiNEERiNG, INC., Infors AG, and Appplikon Biotechnology, Inc.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioreactors Market - Global Industry Insights, Trends, 2026 here

News-ID: 1171378 • Views: 374

More Releases from Coherent Market Insights

Catering and Food Service Contractor Market 2019 In-depth Approaches behind the …
The Global Catering and Food Service Contractor Market report offers majority of the latest and  newest industry data that covers the overall market situation along with  future prospects for Catering and Food Service Contractor market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers,
Ureteral Stents Market 2019 | See Incredible Growth by Top Players HydrUStent, L …
North America is expected to witness lucrative growth in the ureteral stents market, owing to presence of key players such as Becton, Dickinson and Company (Bard Medical), Cook Medical, and Teleflex Incorporated. Moreover, rising prevalence of kidney disorders in the region is also expected to contribute to the North America ureteral stents market growth. For instance, in November 2018, the National Health and Nutrition Examination Survey (NHANES) published their data
Plant-based Vaccines Market 2019 | Potential Growth by Top Key Players Medicago, …
Plants are a cost-effective, safe, and efficacious platform for large-scale production of vaccine in emerging economies and have the potential via oral administration to elicit a mucosal immune response. Key players in the market are focused on Research & Development (R&D) activities for development of plant-based vaccines for the treatment of infectious diseases. This is owing to the ability of plant-based vaccines to be mass produced, with higher efficiency, while
ENT Disorder Treatment Market 2019 | See Incredible Growth by Top Players Sanofi …
The Global ENT Disorder Treatment Market, by Organ Type (Ear, Nose, and Throat), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 9,521.1 million in 2016 and is projected to exhibit a CAGR of 3.2% over the forecast period (2017–2025), as highlighted in a new report published

All 5 Releases


More Releases for Bioreactor

Membrane Bioreactor System Market Revenue and Value Chain 2010-2020
Membrane bioreactor (MBR) is a combination of membrane filtration techniques such as micro filtration and ultra filtration and suspended growth bioreactor. Membrane bioreactors are used widely in large-sized wastewater treatment plants. In membrane bioreactor treatment process, membrane unit is exposed to the sludge that has been treated combine with biological process and the solid-liquid separation process together in the single stage. Membrane bioreactor system (MBR) is very effective against some
Global Mini Bioreactor Market 2018 - ZETA, Danaher, Solaris, Merck KGaA
The statistical surveying information incorporated into the Mini Bioreactor report is the aftereffect of significant essential and optional research exercises. The report fragments the global market for Mini Bioreactor based on makers, item compose, applications, and districts. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the global Mini Bioreactor advertise covering key factors, for example, drivers and
Cellbag Bioreactor Chambers Market 2017-2027: By Application & Scale
Disposable Bioreactors are used for cell cultivation because they improve process flexibility, decrease turn over time and eliminate the cleaning and sterilization process. In these bioreactors cells are grown in a pre-sterilized, inflated chamber called cell bag bioreactor. The culture in the cell bags are agitated by shaking the cellbag attached to the bioreactor tray. Media or culture are exposed to the required temperature by means of heater located below
Membrane Bioreactor System Market to Witness Comprehensive Growth by 2020
Membrane bioreactor (MBR) is a combination of membrane filtration techniques such as micro filtration and ultra filtration and suspended growth bioreactor. Membrane bioreactors are used widely in large-sized wastewater treatment plants. In membrane bioreactor treatment process, membrane unit is exposed to the sludge that has been treated combine with biological process and the solid-liquid separation process together in the single stage. Membrane bioreactor system (MBR) is very effective against some
Single Use Bioreactor Market Assessment 2017-2021
Single use bioreactors are witnessing rapid market growth due to increasing applications in production of antibodies, vaccines, recombinant proteins, growth factors and others. Single use bioreactors are not only used in pharmaceutical companies, but also in biotechnology research laboratories and contract manufacturing organizations. Single use bioreactors assure sterile conditions to quickly initiate production. This greatly reduced chances of cross contamination and increases productivity. Shorter turnaround time due to ease of
Global Membrane Bioreactor Systems Market Research Report 2017
In this report, the global Membrane Bioreactor Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Membrane Bioreactor Systems in these regions, from 2012 to 2022